PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medical Oncology, Faculty of Medicine, Mugla Sitki Kocman University, Mugla, Turkey. mugla.medicaloncology@gmail.com.\', \'Department of Molecular Biology and Genetics, Graduate School of Natural and Applied Sciences, Mugla Sitki Kocman University, Mugla, Turkey. mugla.medicaloncology@gmail.com.\', \'Elderly Health PhD Program Student, Mugla Sitki Kocman University Graduate School of Health Sciences , Mugla Sitki Kocman University Education and Research Hospital, Marmaris Yolu üzeri, Kötekli Mah. Kemoterapi Merkezi, 48000, Mugla, Turkey. mugla.medicaloncology@gmail.com.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s12032-020-01376-8
?:doi
?:hasPublicationType
?:journal
  • Medical oncology (Northwood, London, England)
is ?:pmid of
?:pmid
?:pmid
  • 32333196
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Lymphopenia that may develop in patients treated with temozolomide and immune control check-point inhibitor may be a high risk for mortality during the COVID-19 outbreak.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all